The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the development of products for patients with rare diseases, which affect...

The U.S. Food and Drug Administration today approved Unituxin (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a type of cancer that most often occurs in...

An old disease is getting new recognition as a potential protective agent against infection and subsequent death from the Ebola virus. Nieman-Pick Type C (NPC) is one of three lysosomal storage diseases...